Two UW stem-cell patents upheld
Protein linked to cancer's spread

Madison wins international stem cell summit

City beats New York, D.C.; scientists, investors to attend

Posted: March 13, 2008

Madison - Wisconsin's capital city will host an international stem cell research summit this fall, which will bring up to 1,000 of the world's top researchers, investors and industry representatives to Madison.

The World Stem Cell Summit, to be hosted by the Genetics Policy Institute, WiCell and the University of Wisconsin Stem Cell and Regenerative Medicine Center on Sept. 22 and 23, will mark the 10th anniversary of James Thomson's isolation of human embryonic stem cells at UW-Madison.

The announcement Wednesday came on the heels of an important patent victory for the Wisconsin Alumni Research Foundation. The U.S. Patent and Trademark Office rejected three challenges to three key embryonic stem cell patents.

Thomson is expected to give a keynote address about his latest breakthrough using human skin cells. Stem cells are thought to hold the promise of treatment for diseases such as Alzheimer's and Parkinson's.

This is the fourth meeting of the World Stem Cell Summit. The first three were held at Baylor, Stanford and Harvard universities.

Full story.

Please visit our sponsor Gehrke & Associates, SC to learn more about how to enhance and defend your intellectual property.  Thank you.